Publications by authors named "Ruibin Lin"

Article Synopsis
  • Abemaciclib, one of the CDK4/6 inhibitors for metastatic breast cancer, has fewer side effects due to its preference for inhibiting CDK4 over CDK6.
  • Researchers discovered TQB3616 as a new preferential CDK4 inhibitor, showing better potency against cancer cells compared to approved drugs like palbociclib and abemaciclib.
  • TQB3616, which has a good safety profile, entered clinical development in 2019 and is currently undergoing phase III trials.
View Article and Find Full Text PDF

Acne is a common chronic skin inflammatory disease closely related to(), which affects the life quality of patients worldwide, especially adolescents and young adults. However, the physical barrier of the skin makes drugs difficult to infiltrate effectively into infected site, causing acne hard to cure and easy to recur. Herein, we developed an antibacterial skin dressing with strong infiltration of antibacterial agents which can co-delivery small-molecular antimicrobial agents through stratum corneum deeply into dermis, achieving high antimicrobial efficacy.

View Article and Find Full Text PDF

Surface-enhanced Raman scattering (SERS) of a single ZnO nanorod (NR) is demonstrated by coating with Ag nanoparticles (NPs). An enhancement factor of 1.2×10 and 4.

View Article and Find Full Text PDF